Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor.

Tuttle, Katherine R

Tuttle, Katherine R.

Tuttle KR; Providence Medical Research Center, Providence Health Care, Spokane, Washington, and tuttlk@uw.edu.

Clin J Am Soc Nephrol ; 17(5): 628-630, 2022 05.

Article in English | MEDLINE | ID: covidwho-1817850

Subject(s)

COVID-19; Sodium-Glucose Transporter 2 Inhibitors; Benzhydryl Compounds; Glucosides; Humans; Kidney/drug effects; Paint; Sodium-Glucose Transporter 2 Inhibitors/adverse effects

Keywords

COVID-19; GFR; SARS-CoV-2; SGLT2; acute kidney injury; dapagliflozin; pandemic; safety; sodium-glucose cotransporter 2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Limits: Humans Language: English Journal: Clin J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google